Carsten‐Oliver Sahlmann

573 total citations
13 papers, 433 citations indexed

About

Carsten‐Oliver Sahlmann is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Carsten‐Oliver Sahlmann has authored 13 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Carsten‐Oliver Sahlmann's work include Prostate Cancer Treatment and Research (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Carsten‐Oliver Sahlmann is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Carsten‐Oliver Sahlmann collaborates with scholars based in Germany, Czechia and Portugal. Carsten‐Oliver Sahlmann's co-authors include J. Meller, Alexander Scheel, Birgit Meller, Lutz Trojan, Christian Ritter, Sameh Hijazi, Joachim Lotz, Arne Strauß, Caroline Bouter and Philipp Ströbel and has published in prestigious journals such as European Journal of Medicinal Chemistry, Annals of Surgical Oncology and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Carsten‐Oliver Sahlmann

13 papers receiving 424 citations

Peers

Countries citing papers authored by Carsten‐Oliver Sahlmann

Since Specialization

Citations

This map shows the geographic impact of Carsten‐Oliver Sahlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten‐Oliver Sahlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten‐Oliver Sahlmann more than expected).

Fields of papers citing papers by Carsten‐Oliver Sahlmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten‐Oliver Sahlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten‐Oliver Sahlmann. The network helps show where Carsten‐Oliver Sahlmann may publish in the future.

Co-authorship network of co-authors of Carsten‐Oliver Sahlmann

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten‐Oliver Sahlmann. A scholar is included among the top collaborators of Carsten‐Oliver Sahlmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten‐Oliver Sahlmann. Carsten‐Oliver Sahlmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Development of high-affinity fluorinated ligands for cannabinoid subtype 2 receptor, and in vitro evaluation of a radioactive tracer for imaging 2022 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Christian Breunig, Carsten‐Oliver Sahlmann, Jan Bucerius, Dietmar Stalke, Jens Wiltfang, Yvonne Bouter, Christa E. Müller, Caroline Bouter, Birgit Meller	6
2	The Role of PSMA PET/CT in the Primary Diagnosis and Follow-Up of Prostate Cancer—A Practical Clinical Review 2022 ·Cancers ·(unknown), (unknown), Arne Strauß, Birgit Meller, Jan Bucerius, Carsten‐Oliver Sahlmann	20
3	Mesorectal Lymph Node Metastases as Index Lesion in 68Ga-PSMA-PET/CT Imaging for Recurrent Prostate Cancer 2021 ·Frontiers in Surgery ·(unknown), Marianne Schmid, Carsten‐Oliver Sahlmann, Lutz Trojan, Arne Strauß	1
4	Impact of rs12917 MGMT Polymorphism on [18F]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL) 2019 ·Molecular Imaging and Biology ·(unknown), Lars Kurch, Michaela Čepelová, Ines Volkmer, Axel Sauerbrey, (unknown), (unknown), Gabriele Pöpperl, Daniel Steinbach, Ambros J. Beer, Christof M. Kramm, Carsten‐Oliver Sahlmann, Bernhard Erdlenbruch, (unknown), (unknown), Osama Sabri, Regine Kluge, Martin S. Staege	1
5	Enhancing PSMA-uptake with androgen deprivation therapy – a new way to detect prostate cancer metastases? 2019 ·International braz j urol ·(unknown), Paul Thelen, Marianne Schmid, J. Meller, Carsten‐Oliver Sahlmann, Birgit Meller, Lutz Trojan, Arne Strauß	17
6	Partial Response to First-Line Crizotinib in an Elderly Male Patient with ROS1 Translocation-Positive Lung Cancer 2016 ·Case Reports in Oncology ·Tobias R. Overbeck, Katja Schmitz, Christoph Engelke, Carsten‐Oliver Sahlmann, (unknown), (unknown), Lorenz Trümper, Hans‐Ulrich Schildhaus	6
7	See the unseen: Mesorectal lymph node metastases in prostate cancer 2016 ·The Prostate ·Sameh Hijazi, Birgit Meller, (unknown), Arne Strauß, Christian Ritter, Joachim Lotz, (unknown), Lutz Trojan, Carsten‐Oliver Sahlmann	20
8	Biphasic 68Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma 2015 ·European Journal of Nuclear Medicine and Molecular Imaging ·Carsten‐Oliver Sahlmann, Birgit Meller, Caroline Bouter, Christian Ritter, Philipp Ströbel, Joachim Lotz, Lutz Trojan, J. Meller, Sameh Hijazi	64
9	Individualized Surgery: Gamma-Probe-Guided Lymphadenectomy in Patients with Clinically Enlarged Lymph Node Metastases from Melanomas 2013 ·Annals of Surgical Oncology ·Lutz Kretschmer, Carsten‐Oliver Sahlmann, (unknown), Christina Mitteldorf, Hans‐Joachim Helms, J. Meller, Michael P. Schön, Hans Peter Bertsch	4
10	Long-lasting complete response of metastatic melanoma to ipilimumab with analysis of the resident immune cells 2013 ·Medical Oncology ·(unknown), Inga‐Marie Schaefer, Harald Schwörer, Carsten‐Oliver Sahlmann, Kai‐Martin Thoms, Martina Blaschke, Giuliano Ramadori, Silke Cameron	4
11	Blastomatoid pulmonary carcinosarcoma: report of a case with a review of the literature 2012 ·BMC Cancer ·Inga‐Marie Schaefer, Carsten‐Oliver Sahlmann, Tobias R. Overbeck, Stefan Schweyer, Jan Menke	9
12	18F-FDG PET and PET/CT in fever of unknown origin. 2007 ·PubMed ·J. Meller, Carsten‐Oliver Sahlmann, Alexander Scheel	268
13	Intraoperative Detektion von Sentinel‐Lymphknoten beim malignen Melanom der Haut‐Vitalfärbung allein versus Vitalfärbung plus Gammasonde 2005 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Lutz Kretschmer, (unknown), (unknown), Kai‐Martin Thoms, Christina Mitteldorf, Steffen Emmert, Carsten‐Oliver Sahlmann, Hans Peter Bertsch, Christine Neumann, J. Meller	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact